For the second edition of BioInvestors (Part 3) we are pleased to be joined by key expert investors: Edward Hodgkin, Partner, Syncona, Dina Chaya, Partner, NeoMed, and Roel Bulthuis, Managing Partner, INKEF Capital
Last month, Amber Tong, Senior Editor at Endpoints, chaired a panel of Europe's leading VC investors during the Anglonordic life science conference where they were asked 'What Are The Hot Investment Areas?' Amber was joined by a fantastic panel consisting of Hakan Goker, Deborah Harland, Nanna Lüneborg, and Stephan Christgau. The discussion was extremely captivating, the investors spoke about a range of things including how the pandemic has impacted their business, the essential components to building a successful biotech, and the current hot markets for investment. Watch the panel discussion again here.
Nazneen Rahman BioLeader Interview - Dr Nazneen Rahman, Founder & CEO YewMaker, NED AstraZeneca (June 2021) Nazneen Rahman CBE, MD, PhD, FRCP, FMedSci Nazneen Rahman has made significant contributions to science and medical research over the last 25 years. She is an internationally recognised expert in cancer genomics and was Professor of Human Genetics at the Institute of Cancer Research and Head of Cancer Genetics at the Royal Marsden Hospital, London until 2018. Nazneen is a Non-Executive Director at AstraZeneca, Chair of the AstraZeneca Science Committee and oversees Sustainability for the Board. Nazneen is now focussed on making healthcare [...]
For the second edition of BioInvestors (Part 2) we are pleased to be joined by key expert investors: Edward Hodgkin, Partner, Syncona, Dina Chaya, Partner, NeoMed, and Roel Bulthuis, Managing Partner, INKEF Capital
In May 2020 Kate Bingham was appointed Chair of the UK Vaccine Taskforce, reporting to the Prime Minister to lead UK efforts to find and manufacture a COVID-19 vaccine. This was a six month engagement which Kate stepped down from in December 2020. On December 8th 2020 the UK kicked off its vaccination programme, the first Western country to do so. In recognition of the world-beating and extraordinary success of the UK’s vaccination programme, Kate has been included on the Queen’s Birthday Honours List and awarded a well deserved damehood for her services to the procurement, manufacture and distribution [...]
PIR International recently hosted a panel of Biotech industry experts on the topic of ‘Building your Board’ during the 17th Anglonordic life science conference, doing a deep dive on all things necessary to set-up a successful Board for all stages of growth. As anticipated, it was expertly hosted by Maureen Coleman. Maureen was joined by a superb panel of Eva-Lotta Allen, Edwin Moses, Patrick Vink and Melanie Lee. The discussion was tremendously insightful, providing healthy debate and conversation around all aspects of Board composition, diversity, structure, culture and much more. The utilisation of independent board members, why and when [...]
For the second edition of BioInvestors (Part 1) we are pleased to be joined by key expert investors: Edward Hodgkin, Partner, Syncona, Dina Chaya, Partner, NeoMed, and Roel Bulthuis, Managing Partner, INKEF Capital
Peter Joyce BioLeader Interview - Peter Joyce (April 2021) Peter Joyce is Co-founder and Chief Executive Officer of Grey Wolf, having founded the Company in 2017 with Tom McCarthy. Prior to Grey Wolf Peter was at Vertex Pharmaceuticals where he led drug discovery projects, had responsibility for leading a number of target identification teams that led to multiple novel drug discovery projects and was involved in delivering clinical drug candidates. Peter has a broad scientific experience across therapeutic areas having worked on projects in oncology, genetic diseases and neurodegeneration. He also pioneered the development of complex neurological assays suitable [...]